False Reassurance Based on Non-Significant Results por Douglas G. Altman

Obter o texto integral

Unjustified restrictions on letters to the editor. por Douglas G Altman

Obter o texto integral

Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. por Allison Hirst, Douglas G Altman

Obter o texto integral

Four Proposals to Help Improve the Medical Research Literature. por David Moher, Douglas G Altman

Obter o texto integral

Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. por Peggy Sekula, Susan Mallett, Douglas G Altman, Willi Sauerbrei

Obter o texto integral

Key issues in conducting a meta-analysis of gene expression microarray datasets. por Adaikalavan Ramasamy, Adrian Mondry, Chris C Holmes, Douglas G Altman

Obter o texto integral

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. por Kenneth F Schulz, Douglas G Altman, David Moher, CONSORT Group

Obter o texto integral

Guidance for developers of health research reporting guidelines. por David Moher, Kenneth F Schulz, Iveta Simera, Douglas G Altman

Obter o texto integral

Ítems de referencia para publicar Revisiones Sistemáticas y Metaanálisis: La Declaración PRISMA por David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman, The PRISMA Group

Obter o texto integral

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. por David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman, PRISMA Group

Obter o texto integral

Epidemiology and reporting characteristics of systematic reviews. por David Moher, Jennifer Tetzlaff, Andrea C Tricco, Margaret Sampson, Douglas G Altman

Obter o texto integral

Bland-Altman methods for comparing methods of measurement and response to criticisms por Mohammad Ali Mansournia, Rachel Waters, Maryam Nazemipour, Martin Bland, Douglas G. Altman

Obter o texto integral

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. por Douglas G Altman, Lisa M McShane, Willi Sauerbrei, Sheila E Taube

Obter o texto integral

Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. por Iveta Simera, Douglas G Altman, David Moher, Kenneth F Schulz, John Hoey

Obter o texto integral

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. por Carol Kilkenny, William J Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman

Obter o texto integral

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research por Carol Kilkenny, William J. Browne, Innes C. Cuthill, Michael Emerson, Douglas G. Altman

Obter o texto integral

Uses and misuses of the STROBE statement: bibliographic study por Douglas G Altman, Matthias Egger, Bruno R da Costa, Anne W S Rutjes, Myriam Cevallos

Obter o texto integral

Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers. por Darren Boone, Susan Mallett, Justine McQuillan, Stuart A Taylor, Douglas G Altman, Steve Halligan

Obter o texto integral

Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository. por Catrin Tudur Smith, Kerry Dwan, Douglas G Altman, Mike Clarke, Richard Riley, Paula R Williamson

Obter o texto integral

Ghost authorship in industry-initiated randomised trials. por Peter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, Mette T Haahr, Douglas G Altman, An-Wen Chan

Obter o texto integral